Browsing Tag
Saudi Food and Drug Authority
3 posts
Saudi Arabia becomes next test for whether ANKTIVA can scale beyond U.S. oncology markets
ImmunityBio Inc. launches ANKTIVA in Saudi Arabia with pricing approval and regional partners. Find out why this move matters for global oncology strategy.
ImmunityBio (NASDAQ: IBRX) secures Saudi FDA approval for ANKTIVA in BCG-unresponsive bladder cancer
ImmunityBio secures Saudi approval for ANKTIVA in NMIBC. Find out how this reshapes the company’s MENA strategy and immunotherapy ambitions.
Co-Diagnostics (Nasdaq: CODX) launches clinical trial for multiplex respiratory test as FDA approval push begins
Co-Diagnostics launches trial for flu, COVID-19, RSV test kit targeting FDA clearance. Learn how it plans to lead in decentralized respiratory diagnostics.